GUTS today
$0.81-$0.07 (-7.84%)close Nov 12, 2026Trend
DailyDowntrend (confirmed)
4 hourSymmetric Triangle
1 hourStrong Bearish
15 minBearish
5 minStrong Bearish
Daily trend turns up above $1.02
Key levels
Resistance$4.58
Resistance$4.14
Support$0.80
Latest news & SEC filings
NewsFractyl Health adds Michael Wartell to its board of directors
SEC FilingFractyl Health, Inc. filed a report on a major company event (Form 8-K)
All GUTS news →About Fractyl Health
Fractyl Health is a medical device and gene therapy company developing treatments for metabolic diseases. Its lead product candidate, Revita, is a device-based procedure, while its Rejuva program focuses on gene therapies. The company operates in the United States and Europe, targeting patients with type 2 diabetes and other metabolic conditions.
Based on the company's 10-K filed Mar 24, 2026.
Nasdaq · Healthcare
FRACTYL HEALTH, INC. (GUTS)
What Is the Price Target for GUTS?
SEPT Low Target
$4.00
SEPT Mid Target
$6.00
SEPT High Target
$8.00
Analyst Consensus
$6.00
Is GUTS a Buy or Sell Right Now?
Thesis
- •Revenue growing -22.5% YoY with UNKNOWN trend — consistent growth.
- •Smart money flows are positive — institutional and insider activity shows net buying.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for GUTS.
Start Free Trial →Is GUTS Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
Analyst Consensus
Fair Value
$6.00
0
Moat Score
NONE
2/9
Piotroski Score
-8.0
Altman Z-Score
What Is Smart Money Doing with GUTS?
Insider Signal
BUYING
6 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| BRADLEY WILLIAM | director | Buy | 64,516 | $40K | Sep 14, 2026 |
| Royan Ajay | director | Buy | 23,000 | $20K | Jun 12, 2026 |
| BRADLEY WILLIAM | director | Buy | 68,493 | $50K | Jun 10, 2026 |
| Sheffield Ian | director | Buy | 35,000 | $26K | Jun 10, 2026 |
| Rajagopalan Harith | director officer | Buy | 25,000 | $18K | Jun 10, 2026 |
| Smith Weber Lara | officer | Buy | 20,000 | $14K | Jun 8, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →GUTS Growth Story
Revenue YoY
-22.5%
3yr Revenue CAGR
N/A%
EPS Growth YoY
-14.81%
FCF Growth YoY
-35.1%
Revenue Trend
UNKNOWN
Dark Pool Trades for GUTS
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for GUTS, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 15:35:03 | $0.88 | 1,000 | $$878 | SELL |
| 15:31:55 | $0.88 | 5,400 | $$5K | SELL |
| 15:13:32 | $0.87 | 1,900 | $$2K | SELL |
| 14:47:37 | $0.85 | 4,400 | $$4K | SELL |
| 14:30:12 | $0.87 | 1,496 | $$1K | SELL |
5 dark pool trades shown · $$12K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for FRACTYL HEALTH, INC. (GUTS) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →GUTS — frequently asked questions
What is GUTS stock price today?
FRACTYL HEALTH, INC. (GUTS) is at $0.81, down 7.84% (-$0.07) at the Nov 12, 2026 close.
Why is GUTS stock moving today?
Latest GUTS news — Nov 7, 2026: Fractyl Health adds Michael Wartell to its board of directors · Nov 6, 2026: Fractyl Health, Inc. filed a report on a major company event (Form 8-K)
Why did GUTS stock move on Oct 16, 2026?
Fractyl Health shares plunged 27.57% to close at $1.55 on heavy volume of over 6.3 million shares, despite the company announcing that its REMAIN-1 study met its six-month co-primary endpoint with high statistical significance, demonstrating 80% retention of GLP-1 induced weight loss versus 67% for sham. The sharp selloff suggests investors focused on the fact that the second co-primary endpoint and 12-month results are not expected until 2027, leaving a long timeline of uncertainty ahead.
What is the GUTS price target?
The average analyst price target for GUTS is $6.00, ranging from $4 to $8, based on 2 analysts. Latest: Morgan Stanley maintains on Oct 19, 2026.
What do analysts rate GUTS?
Analyst ratings for GUTS: 0 Buy, 4 Hold, 0 Sell — consensus Hold.
Did GUTS beat earnings?
GUTS last reported on Aug 10, 2026: EPS -$0.12 vs -$0.14 expected — a beat of 11.1%.
Does GUTS pay a dividend?
GUTS does not currently pay a dividend.
What are GUTS support and resistance levels?
Support: $0.80. Resistance: $4.14, $4.58, $6.72.
What are insiders doing with GUTS?
Insider activity: BUYING, 6 buys and 0 sells in the last 90 days.
What is the latest news on GUTS?
Nov 7, 2026: Fractyl Health adds Michael Wartell to its board of directors · Nov 6, 2026: Fractyl Health, Inc. filed a report on a major company event (Form 8-K)